Market Cap 372.78B
Revenue (ttm) 33.72B
Net Income (ttm) 12.15B
EPS (ttm) N/A
PE Ratio 27.92
Forward PE 22.20
Profit Margin 36.03%
Debt to Equity Ratio 0.47
Volume 21,265,200
Avg Vol 7,355,290
Day's Range N/A - N/A
Shares Out 4.49B
Stochastic %K 37%
Beta 0.45
Analysts Strong Sell
Price Target $126.75

Latest News on NVO

Dr. Kavita Patel talks impact of GLP-1 price negotiations

Jan 17, 2025, 6:45 PM EST - 4 hours ago

Dr. Kavita Patel talks impact of GLP-1 price negotiations

LLY


3-Stock Lunch: Intel, Sherwin-Williams & Novo Nordisk

Jan 17, 2025, 3:34 PM EST - 7 hours ago

3-Stock Lunch: Intel, Sherwin-Williams & Novo Nordisk

INTC SHW


Ozempic, Wegovy among drugs subject to Medicare price controls

Jan 17, 2025, 11:55 AM EST - 10 hours ago

Ozempic, Wegovy among drugs subject to Medicare price controls

LLY


Ozempic Among the Next Drugs Up for Medicare Price Negotiations

Jan 17, 2025, 11:10 AM EST - 11 hours ago

Ozempic Among the Next Drugs Up for Medicare Price Negotiations


Finally An Attractive Entry Point Into Novo Nordisk

Jan 16, 2025, 7:56 AM EST - 1 day ago

Finally An Attractive Entry Point Into Novo Nordisk


Novo Nordisk: Excellent Opportunity To Buy The Dip

Jan 15, 2025, 7:42 AM EST - 2 days ago

Novo Nordisk: Excellent Opportunity To Buy The Dip


Novo Nordisk A/S - share repurchase programme

Jan 13, 2025, 8:52 AM EST - 4 days ago

Novo Nordisk A/S - share repurchase programme


How a new Denmark tariff could impact Novo Nordisk

Jan 8, 2025, 10:54 AM EST - 9 days ago

How a new Denmark tariff could impact Novo Nordisk


Novo Nordisk Needs Answers to These 5 Key Questions

Jan 8, 2025, 2:00 AM EST - 9 days ago

Novo Nordisk Needs Answers to These 5 Key Questions


GLP-1 makers could be under pressure in 2025

Jan 6, 2025, 7:29 PM EST - 11 days ago

GLP-1 makers could be under pressure in 2025

LLY XLV


Novo Nordisk: Be Greedy When Others Are Fearful

Jan 1, 2025, 3:11 AM EST - 16 days ago

Novo Nordisk: Be Greedy When Others Are Fearful


Weight-loss drug investments: why 2025 could be a game-changer

Dec 31, 2024, 12:38 PM EST - 17 days ago

Weight-loss drug investments: why 2025 could be a game-changer

LLY


Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst

Dec 29, 2024, 9:00 AM EST - 19 days ago

Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst


Will Novo Nordisk (NVO) Stock Recover To $145 Levels?

Dec 24, 2024, 12:15 AM EST - 24 days ago

Will Novo Nordisk (NVO) Stock Recover To $145 Levels?


The Big 3: CAT, NVO, VZ

Dec 23, 2024, 12:42 PM EST - 25 days ago

The Big 3: CAT, NVO, VZ

CAT VZ


Novo Nordisk's 27% drop was market overreaction, analysts say

Dec 23, 2024, 6:14 AM EST - 25 days ago

Novo Nordisk's 27% drop was market overreaction, analysts say


US FDA approves Novo Nordisk's bleeding disorder drug

Dec 20, 2024, 6:42 PM EST - 4 weeks ago

US FDA approves Novo Nordisk's bleeding disorder drug


Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher

Dec 20, 2024, 1:05 PM EST - 4 weeks ago

Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher